Hancock Jaffe Laboratories: Funding, Investors & Team (Sep 2026)
Hancock Jaffe Laboratories develops life-enhancing bioprosthetic devices and technologies intended to achieve unparalleled outcomes for patients with debilitating cardiovascular diseases. Each device is designed to allow vascular and cardiothoracic surgeons to achieve maximum effectiveness while greatly reducing the time and complexity of current procedures in concert with a commitment to efficient health care delivery. Founded in 1987 by Norman Jaffe, Hancock Jaffe Laboratories is headquartered in Irvine, California.
Hancock Jaffe Laboratories has raised $20.0M across 1 funding round on record, the most recent a Post-IPO Equity of $20.0M announced in Sep 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Hancock Jaffe Laboratories Company Profile and Key Stats
Latest funding round on record: Sep 2021.
Hancock Jaffe Laboratories Funding Rounds
Hancock Jaffe Laboratories Founders and Leadership Team
Contact details for the Hancock Jaffe Laboratories team: 1 of 1 has an email address on file.
Start 14-day free trial →Hancock Jaffe Laboratories Funding Compared to Other Biotechnology Startups
Hancock Jaffe Laboratories' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Hancock Jaffe Laboratories in Biotechnology and Irvine
Companies Similar to Hancock Jaffe Laboratories
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
Hancock Jaffe Laboratories Funding FAQs
What does Hancock Jaffe Laboratories do?
Hancock Jaffe Laboratories develops life-enhancing bioprosthetic devices and technologies intended to achieve unparalleled outcomes for patients with debilitating cardiovascular diseases. Each device is designed to allow vascular and cardiothoracic surgeons to achieve maximum effectiveness while greatly reducing the time and complexity of current procedures in concert with a commitment to efficient health care delivery. Founded in 1987 by Norman Jaffe, Hancock Jaffe Laboratories is headquartered in Irvine, California.
How much funding has Hancock Jaffe Laboratories raised?
Hancock Jaffe Laboratories has raised $20.0M across 1 round on record. The most recent is a Post-IPO Equity of $20.0M announced in Sep 2021.
When did Hancock Jaffe Laboratories last raise funding?
Hancock Jaffe Laboratories' most recent funding round on record is a Post-IPO Equity of $20.0M, announced in Sep 2021.
Who is the CEO of Hancock Jaffe Laboratories?
Robert Berman is listed as CEO at Hancock Jaffe Laboratories.
Where is Hancock Jaffe Laboratories headquartered?
Hancock Jaffe Laboratories is based in Irvine, California, United States.
How many employees does Hancock Jaffe Laboratories have?
Hancock Jaffe Laboratories is in the 11-50 employee band.
How does Hancock Jaffe Laboratories' funding compare to other Biotechnology startups?
Hancock Jaffe Laboratories' latest round of $20.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Hancock Jaffe Laboratories Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Hancock Jaffe Laboratories is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.